HON
57
-3
JNPR
59
-3
HES
68
2
COST
57
4
EW
36
2
ADT
61
11
FDX
36
-3
MCO
71
-2
GM
46
-4
BA
39
4
EQIX
62
3
IRM
39
-5
DTE
67
2
HCA
50
4
D
55
2
SPG
45
2
XEL
58
7
VIX
38
-6
SCHW
61
5
EOG
54
-2
HON
57
-3
JNPR
59
-3
HES
68
2
COST
57
4
EW
36
2
ADT
61
11
FDX
36
-3
MCO
71
-2
GM
46
-4
BA
39
4
EQIX
62
3
IRM
39
-5
DTE
67
2
HCA
50
4
D
55
2
SPG
45
2
XEL
58
7
VIX
38
-6
SCHW
61
5
EOG
54
-2
Financhill
Back

OncoCyte Stock Predictions

Access "King of the Quants" Stock Rating System FREE!

[Claim Your 3 Free Grades Now]
Sell
30

OCX
OncoCyte

Last Price:
$2.08
Seasonality Move:
11.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Access to "King of the Quants" Stock Rating System

[Claim Your 3 Free Grades Now]

OncoCyte Stock Forecast

  • Is OncoCyte Stock Undervalued?
    The current OncoCyte [OCX] share price is $2.08. The Score for OCX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will OncoCyte Stock Go Up Next Year?

Data Unavailable

OncoCyte Stock Rating

Data Unavailable

OncoCyte Stock Price History

Is OCX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oncocyte.com

52-Week Data

52-Week High:
3.48
52-Week Low:
1.97

Prediction Charts

Market Cap:
35M
Price in USD:
2.08
Volume:
28.1K
Beta:
1.86

Technical Analysis

SMA50:
2.44
SMA100:
2.75
SMA200:
2.82
52-Wk Change:
-39.71%

Stock Predictions

  • Is OncoCyte stock public?
    Yes, OncoCyte is a publicly traded company.
  • What is the OncoCyte stock quote today?
    The OncoCyte stock price is 2.08 USD today.
  • How to buy OncoCyte stock online?
    You can buy OncoCyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-27 1.97 2.11 2.20 1.97
Dec-30 2.25 2.45 2.69 2.16
Dec-31 2.52 2.38 2.60 2.33
Jan-2 2.31 2.33 2.39 2.23
Jan-3 2.37 2.37 2.38 2.31
Jan-6 2.39 2.29 2.45 2.23
Jan-7 2.32 2.22 2.43 2.18
Jan-8 2.30 2.23 2.33 2.18
Jan-10 2.26 2.21 2.32 2.13
Jan-13 2.20 2.08 2.31 2.06
Jan-14 2.10 2.15 2.28 2.05
Jan-15 2.18 2.20 2.20 2.08
Jan-16 2.24 2.10 2.24 2.08
Jan-17 2.15 2.08 2.15 2.08

OncoCyte Earnings

Data Unavailable

OncoCyte Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.00 per share.

* OncoCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.